)
)
)
Syenex, Inc.
Royalty-Free, In Vivo T Cell Engineering Platform: VivoCell™
Syenex develops scalable, targeted enveloped vectors for delivery of DNA, RNA, CAS editors into immune cells, stem cells, & hepatocytes—both ex vivo and in vivo (>50 partners | DMF + GMP production est. 2025)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)